Journal of Gastric Cancer

The Korean Gastric Cancer Association (대한위암학회)
권호 표지
DOI QR코드

DOI QR Code

Endoscopic Submucosal Dissection for Superficial Barrett's Neoplasia in Korea: a Single-Center Experience

  • Joo, Dong Chan (Department of Internal Medicine, Pusan National University College of Medicine) ;
  • Kim, Gwang Ha (Department of Internal Medicine, Pusan National University College of Medicine) ;
  • Lee, Bong Eun (Department of Internal Medicine, Pusan National University College of Medicine) ;
  • Lee, Moon Won (Department of Internal Medicine, Pusan National University College of Medicine) ;
  • Baek, Dong Hoon (Department of Internal Medicine, Pusan National University College of Medicine) ;
  • Song, Geun Am (Department of Internal Medicine, Pusan National University College of Medicine) ;
  • Lee, Sojeong (Department of Pathology, Pusan National University College of Medicine) ;
  • Park, Do Youn (St. Maria Pathology Laboratory)
  • Received : 2021.11.01
  • Accepted : 2021.12.20
  • Published : 2021.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: While the incidence of Barrett's neoplasia has been increasing in Western countries, the disease remains rare in Asian countries. Therefore, very few studies have investigated the endoscopic treatment for Barrett's neoplasia in Korea. Endoscopic submucosal dissection (ESD) enables en bloc and complete resection of gastrointestinal neoplastic lesions. This study aimed to evaluate the therapeutic outcomes of ESD for Barrett's neoplasia in a single center in Korea and to examine the predictive factors for incomplete resection. Materials and Methods: We conducted a retrospective observational study of 18 patients who underwent ESD for superficial Barrett's neoplasia (dysplasia and early cancer) between January 2010 and December 2019 at Pusan National University Hospital. The therapeutic outcomes of ESD and procedure-related complications were analyzed. Results: En bloc resection, complete resection, and curative resection were performed in 94%, 72%, and 61% of patients, respectively. Histopathology (submucosal or deeper invasion of the tumor) was a significant predictive factor for incomplete resection (P=0.047). Procedure-related bleeding and stenosis were not observed, whereas perforation occurred in one case. During the median follow-up period of 12 months (range, 6-74 months), local recurrence occurred in 2 patients with incomplete resection, one patient underwent repeat ESD, and the other patient received concurrent chemoradiotherapy. The 3-year overall and disease-specific survival rates were 73% and 93%, respectively. Conclusions: ESD seems to be an effective and safe treatment for superficial Barrett's neoplasia in Korea. Nevertheless, the suitability of ESD for Barrett's cancer cases should be determined considering the high risk of deep submucosal invasion.

Keywords

Acknowledgement

This study was supported by the Medical Research Center Program through a National Research Foundation Grant funded by the Korean Government (NRF-2015R1A5A2009656).

References

  1. de Jonge PJ, van Blankenstein M, Looman CW, Casparie MK, Meijer GA, Kuipers EJ. Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study. Gut 2010;59:1030-1036. https://doi.org/10.1136/gut.2009.176701
  2. Bhat S, Coleman HG, Yousef F, Johnston BT, McManus DT, Gavin AT, et al. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. J Natl Cancer Inst 2011;103:1049-1057. https://doi.org/10.1093/jnci/djr203
  3. Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000;29:645-654. https://doi.org/10.1093/ije/29.4.645
  4. Vizcaino AP, Moreno V, Lambert R, Parkin DM. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer 2002;99:860-868. https://doi.org/10.1002/ijc.10427
  5. Goda K, Singh R, Oda I, Omae M, Takahashi A, Koike T, et al. Current status of endoscopic diagnosis and treatment of superficial Barrett's adenocarcinoma in Asia-Pacific region. Dig Endosc 2013;25 Suppl 2:146-150. https://doi.org/10.1111/den.12093
  6. Wu JC. Gastroesophageal reflux disease: an Asian perspective. J Gastroenterol Hepatol 2008;23:1785-1793. https://doi.org/10.1111/j.1440-1746.2008.05684.x
  7. Shaheen NJ, Falk GW, Iyer PG, Gerson LB; American College of Gastroenterology. ACG clinical guideline: diagnosis and management of Barrett's esophagus. Am J Gastroenterol 2016;111:30-50. https://doi.org/10.1038/ajg.2015.322
  8. Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut 2014;63:7-42. https://doi.org/10.1136/gutjnl-2013-305372
  9. Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T, Repici A, Vieth M, De Ceglie A, et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 2015;47:829-854. https://doi.org/10.1055/s-0034-1392882
  10. Pech O, Behrens A, May A, Nachbar L, Gossner L, Rabenstein T, et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008;57:1200-1206. https://doi.org/10.1136/gut.2007.142539
  11. Titi M, Overhiser A, Ulusarac O, Falk GW, Chak A, Wang K, et al. Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett's esophagus. Gastroenterology 2012;143:564-566.e1. https://doi.org/10.1053/j.gastro.2012.04.051
  12. Joo DC, Kim GH, Park DY, Jhi JH, Song GA. Long-term outcome after endoscopic submucosal dissection in patients with superficial esophageal squamous cell carcinoma: a single-center study. Gut Liver 2014;8:612-618. https://doi.org/10.5009/gnl13130
  13. Kim JK, Kim GH, Lee BE, Park CH, Jeon HK, Baek DH, et al. Endoscopic submucosal dissection for esophagogastric junction tumors: a single-center experience. Surg Endosc 2018;32:760-769. https://doi.org/10.1007/s00464-017-5735-2
  14. Chevaux JB, Piessevaux H, Jouret-Mourin A, Yeung R, Danse E, Deprez PH. Clinical outcome in patients treated with endoscopic submucosal dissection for superficial Barrett's neoplasia. Endoscopy 2015;47:103-112. https://doi.org/10.1055/s-0034-1390982
  15. Kagemoto K, Oka S, Tanaka S, Miwata T, Urabe Y, Sanomura Y, et al. Clinical outcomes of endoscopic submucosal dissection for superficial Barrett's adenocarcinoma. Gastrointest Endosc 2014;80:239-245. https://doi.org/10.1016/j.gie.2014.01.022
  16. Sharma P, McQuaid K, Dent J, Fennerty MB, Sampliner R, Spechler S, et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 2004;127:310-330. https://doi.org/10.1053/j.gastro.2004.04.010
  17. Japan Esophageal Society. Japanese classification of esophageal cancer, 11th edition: part I. Esophagus 2017;14:1-36. https://doi.org/10.1007/s10388-016-0551-7
  18. Participants in the Paris Workshop. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 2003;58:S3-S43. https://doi.org/10.1016/S0016-5107(03)02159-X
  19. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-180. https://doi.org/10.1136/gut.45.2.172
  20. Cheong JH, Kim GH, Lee BE, Choi MK, Moon JY, Ryu DY, et al. Endoscopic grading of gastroesophageal flap valve helps predict proton pump inhibitor response in patients with gastroesophageal reflux disease. Scand J Gastroenterol 2011;46:789-796. https://doi.org/10.3109/00365521.2011.579154
  21. Kimura K, Satoh K, Ido K, Taniguchi Y, Takimoto T, Takemoto T. Gastritis in the Japanese stomach. Scand J Gastroenterol Suppl 1996;214:17-20.
  22. Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-255. https://doi.org/10.1136/gut.47.2.251
  23. Manner H, Pech O, Heldmann Y, May A, Pauthner M, Lorenz D, et al. The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns. Surg Endosc 2015;29:1888-1896. https://doi.org/10.1007/s00464-014-3881-3
  24. Ishihara R, Oyama T, Abe S, Takahashi H, Ono H, Fujisaki J, et al. Risk of metastasis in adenocarcinoma of the esophagus: a multicenter retrospective study in a Japanese population. J Gastroenterol 2017;52:800-808. https://doi.org/10.1007/s00535-016-1275-0
  25. Shimizu T, Fujisaki J, Omae M, Yamasaki A, Horiuchi Y, Ishiyama A, et al. Treatment outcomes of endoscopic submucosal dissection for adenocarcinoma originating from long-segment Barrett's esophagus versus short-segment Barrett's esophagus. Digestion 2018;97:316-323. https://doi.org/10.1159/000486197
  26. Subramaniam S, Chedgy F, Longcroft-Wheaton G, Kandiah K, Maselli R, Seewald S, et al. Complex early Barrett's neoplasia at 3 Western centers: European Barrett's Endoscopic Submucosal Dissection Trial (E-BEST). Gastrointest Endosc 2017;86:608-618. https://doi.org/10.1016/j.gie.2017.01.027
  27. Chung JW, Lee GH, Jung HY, Choi KD, Song HJ, Choi KS, et al. Clinicopathologic characteristics of Barrett's cancer in Korea. Gut Liver 2008;2:193-198. https://doi.org/10.5009/gnl.2008.2.3.193
  28. Osumi H, Fujisaki J, Omae M, Shimizu T, Yoshio T, Ishiyama A, et al. Clinicopathological features of Siewert type II adenocarcinoma: comparison of gastric cardia adenocarcinoma and Barrett's esophageal adenocarcinoma following endoscopic submucosal dissection. Gastric Cancer 2017;20:663-670. https://doi.org/10.1007/s10120-016-0653-x
  29. Probst A, Aust D, Markl B, Anthuber M, Messmann H. Early esophageal cancer in Europe: endoscopic treatment by endoscopic submucosal dissection. Endoscopy 2015;47:113-121. https://doi.org/10.1055/s-0034-1391086
  30. Park HC, Kim DH, Gong EJ, Na HK, Ahn JY, Lee JH, et al. Ten-year experience of esophageal endoscopic submucosal dissection of superficial esophageal neoplasms in a single center. Korean J Intern Med 2016;31:1064-1072. https://doi.org/10.3904/kjim.2015.210
  31. Shimamura Y, Ikeya T, Marcon N, Mosko JD. Endoscopic diagnosis and treatment of early esophageal squamous neoplasia. World J Gastrointest Endosc 2017;9:438-447. https://doi.org/10.4253/wjge.v9.i9.438
  32. Matsui A, Kuribayashi Y, Nomura K, Tanaka T, Toba T, Yamada A, et al. Conventional white light endoscopic features of small superficial Barrett's esophageal adenocarcinoma. Digestion 2016;93:47-52. https://doi.org/10.1159/000441764
  33. Anders M, Lucks Y, El-Masry MA, Quaas A, Rosch T, Schachschal G, et al. Subsquamous extension of intestinal metaplasia is detected in 98% of cases of neoplastic Barrett's esophagus. Clin Gastroenterol Hepatol 2014;12:405-410. https://doi.org/10.1016/j.cgh.2013.07.013
  34. Jang YS, Lee BE, Kim GH, Park DY, Jeon HK, Baek DH, et al. Factors associated with outcomes in endoscopic submucosal dissection of gastric cardia tumors: a retrospective observational study. Medicine (Baltimore) 2015;94:e1201. https://doi.org/10.1097/MD.0000000000001201
  35. Jung JI, Kim GH, I H, Park DY, Kim TK, Cho YH, et al. Clinicopathologic factors influencing the accuracy of EUS for superficial esophageal carcinoma. World J Gastroenterol 2014;20:6322-6328. https://doi.org/10.3748/wjg.v20.i20.6322
  36. Qumseya BJ, Brown J, Abraham M, White D, Wolfsen H, Gupta N, et al. Diagnostic performance of EUS in predicting advanced cancer among patients with Barrett's esophagus and high-grade dysplasia/early adenocarcinoma: systematic review and meta-analysis. Gastrointest Endosc 2015;81:865-874.e2. https://doi.org/10.1016/j.gie.2014.08.025
  37. Anders M, Bahr C, El-Masry MA, Marx AH, Koch M, Seewald S, et al. Long-term recurrence of neoplasia and Barrett's epithelium after complete endoscopic resection. Gut 2014;63:1535-1543. https://doi.org/10.1136/gutjnl-2013-305538
  38. Abe S, Ishihara R, Takahashi H, Ono H, Fujisaki J, Matsui A, et al. Long-term outcomes of endoscopic resection and metachronous cancer after endoscopic resection for adenocarcinoma of the esophagogastric junction in Japan. Gastrointest Endosc 2019;89:1120-1128. https://doi.org/10.1016/j.gie.2018.12.010
  39. Pech O, May A, Manner H, Behrens A, Pohl J, Weferling M, et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 2014;146:652-660.e1. https://doi.org/10.1053/j.gastro.2013.11.006
  40. Hongo M. Review article: Barrett's oesophagus and carcinoma in Japan. Aliment Pharmacol Ther 2004;20 Suppl 8:50-54. https://doi.org/10.1111/j.1365-2036.2004.02230.x